CXCL2 and neoplasm: In a pancreatic cancer model, Chan et al.74 found that melatonin induces tumor cells to secrete CXCL2, recruiting TANs, which adopt an N1-like anti-tumor phenotype, release NETs, and promote tumor apoptosis via ROS-dependent NETosis.